公司資料
Aridis Pharmaceuticals 股價、新聞與催化劑
- 股票代碼:
- ARDS
- 交易所:
- NASDAQ
- 產業:
- Biopharma
- 所在地:
- United States
股票表現
0.00 USD (0.00%)
收盤價
最後更新: 2026年9月18日
—
市值
股價為何變動
截至 2026年9月18日，ARDS 股價變化不大，收於 $0.0001。目前新聞監測窗口內未發現新的同公司新聞。
公司概覽
業務概覽
Aridis Pharmaceuticals is a biotechnology company focused on antibody-based therapies for infectious disease and respiratory infections. Its story is centered on using targeted biologics to tackle stubborn pathogens.
所在地與產業分類
Aridis is headquartered in the United States and listed on NASDAQ. It sits in small-cap anti-infective biotechnology.
商業模式特徵
The company depends on clinical validation, regulatory strategy, and the ability to keep a narrow pipeline funded. Investors usually watch proof-of-concept data and partnership interest.
生技產業定位
Aridis occupies a niche anti-infective position within biotech. The stock is driven by whether its biologic approach can matter in difficult infection settings.
未來催化劑
- Aridis is largely a legacy / closeout story, with catalysts limited to any strategic or asset-resolution update. The market no longer treats it as a live development name.
近期新聞
新聞標題由機器翻譯，詳情為英文原文。
相似股票
商業成熟度、治療領域或催化劑模式相近的同業公司。